Loading clinical trials...
Loading clinical trials...
Meningiomas, which account for about 40% of primary central nervous system tumors, have significant psychological and social impacts, even without treatment. Their effect on quality of life is often underestimated and poorly documented. There is one validated questionnaire (MQOL) but it has not yet been translated into French. The project involves two phases: first, translating and linguistically validating the MQOL into French; second, scientifically validating the questionnaire with 50 meningioma patients using established scales (EQ-5D, Karnofsky, FACT-Br) to ensure its reliability and internal consistency.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
GHU Paris -Psychiatrie & Neurosciences
Paris, France
Start Date
June 13, 2025
Primary Completion Date
July 13, 2025
Completion Date
December 12, 2025
Last Updated
June 29, 2025
50
ESTIMATED participants
Quality of life
OTHER
Lead Sponsor
Centre Hospitalier St Anne
NCT05940493
NCT02523014
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07444697